Beruflich Dokumente
Kultur Dokumente
ARTIGO Nº
A. Yagi, et al., Radical Scavenging Glycoprotein Inhibiting Cyclooxigenase-2 99
and Thromboxane A2 Synthase from Aloe vera Gel, Planta Med, n. 69, p.
269-271, 2003
ACUTE intoxication of cyclosporin caused by coadministration of decoctions 40
of the fruits of Citrus aurantium and the Pericarps of Citrus grandis. Planta
Med., v. 66, p. 653-655. 2000.
ADLERCREUTZ H. Phyto-oestrogens and cancer. . REVIEW.. The Lancet 94
Oncology, v 3, 364-373, 2002.
ALBERT, A., et al. Efficacy and safety of a phytoestrogen preparation derived 128
from Glycine max (L.) Merr in climateric symptomalogy: A multicentric, open,
prospective and non-randomized trial. Phytomedicine, v. 9, p. 85-92, 2002
ALBERTAZZI, Paola, et al. The Effect of Dietary Soy Supplementation on Hot 124
Flushes. Obstetrics & Gynecology, v. 91, n. 1, 1998
ALBERTAZZI, Paola, et al. The nature and utility of the phytoestrogens: a 140
review of the evidence. Maturitas, v. 42, p. 173-185, 2002
ALEKEL, D. Lee, et al. Isoflavone-rich soy protein isolate attenuates bone loss 120
in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr., v. 72, p.
844-852, 2000
ANGELL, Marcia, KASSIRER, J. P. Alternative medicine : the risks of 25
untested and unregulated remedies. The New England Journal of Medicine,
v. 339, n. 12, p.839-841. 1998.
ANTHONY M. S., et al. Soybean Isoflavones Improve Cardiovascular Risk 148
Factors Without Affecting The Reproductive System of Peripubertal Rhesus
Monkeys. Journal of Nutrition, v. 126, n. 1, p. 43-50,1996
ATTEELE, Anoja, et al. Ginseng pharmacology : multiple constituents and 63
multiple actions. Biochemical Pharmacology, v.58, p.1685-1693. 1999.
AUNE B., et al. Hormone Replacement Therapy Reduces the Reactivity of 147
Monocytes and Plateles in Whole Blood – a Beneficial Effect on
Atherogenesis and Thrombus Formation?. Am. J. Obstet. Gynecol., v. 173,
n. 6, p. 1816-1820, 1995
BARNES, Stephen, et al. Rationale for the Use of Genistein-Containing Soy 112
Matrices in Chemoprevention Trials for Breast and Prostate Cancer. Journal
of Cellular Biochemistry, supl. 22, p. 181-187, 1995
BARNES, Stephen. Soy Protein Isoflavone Effects on Breast Tissue. “The 141
Health of Soy Protein Symposium” UCLA Center for Human Nutrition,
1998
BARRETT, B. Medicinal properties of Echinacea: a critical review. . 72
Phytomedicine, v. 10, p. 66-86, 2003.
BAUER, S. et al. Differential effects of Saint John´s Wort (Hypericum 74
perforatum) on the urinary excretion of D-glucaric acid and 6-hydroxycortisol
in healthy volunteers. . Phytomedicine, v. 58, p. 581-585, 2002.
BEAULIEU, J.E. Herbal Therapy Interactions with Immunosuppressive 12
Agents. Pharmacist, v. 26:27. 2001.
BENASSAYAG, C. Phytoestrogens as modulatory of steroid action in target 69
cells. Journal of Chromatography B, v. 777, p. 223-248, 2002.
BHATTARAM, Venkastesh Atul, et al. Pharmacokinetics and Bioavailability of 105
Herbal Medicinal Products. Phytomedicine, n. 9, supplement III, p. 1-33,
2002
BIANCO, A., et al. Iridoids-XXIII: Isolation of Aucubigenin and Its Acid- 133
Catalyzed Rearrangement. Tetrahedron, v. 33, p. 847-850, 1977
BIFFIGNANDI, P. M., BILIA, A.R. The Growing Knowledge of St. Johns Wort 16
(Hypericum perforatum L) Drug Interactions and Their Clinical Significance.
Current Therapeutic Research. v. 61, n. 7, p. 389-394. 2000.
BILIA, A. R. Ginkgo biloba L. Fitoterapia, v. 73, p. 276-279. 2002. 05
BILIA, A. R., et al. St. Jonh’s Wort and depression efficacy, safety and toleraty 02
– an update. Life Sciences, v. 70, p. 3077-3096. 2002.
BONE, Kerry; Clinical Update. British Journal of Phytotherapy, v. 5, n. 4, p. 98
209-217,2002 (Hypericum perfloratum, Ginkgo Biloba, Vitex)
BORRELLI, F., ERNST, E. Cimicifuga racemosa: a systematic review of its 04
clinical efficacy. Eur. J. Clin. Pharmacol., v. 58, p. 235-241. 2002.
BRAY, B.J., et al. Short term treatment with St. John’s Wort, hypericin or 23
hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. Life
Sciences, v. 70, p.1325-1335. 2002.
BRISKIN, Donald P. Medicinal plants and phytomedicines. Linking plant 34
biochemistry and physiology to human health. Plant Physiology, v. 124, p.
507-514. 2000.
BÜLOW, Nils, KÖNIG, Wilfried A. The role of germacrene D as a precursor in 61
sesquiterpene biosynthesis: investigations of acid catalyzed, photochemically
and thermally induced rearrangements. Phytochemistry, v.55, p.141-168.
2000.
BURTON, J. L. et al. The effect of phytoestrogens on the female genital 88
tract. . Journal Clin Pathol, v55, 401-407, 2002.
CAPASSO, Raffaele, et al. Phytotherapy and quality of herbal medicines. 58
Fitoterapia, v.71, p. S58-s65. 2000.
CARVALHO, Paulo Sergio Perri, et al. Cicatrização Cutânea Após Aplicação 136
Tópca de Creme de Calêndula e da Associação de Confrei, Própolis e Mel
em Feridas Infectadas – Estudo Clinico e Histológico em Ratos. Revista de
Ciências Biomédicas, v. 12, p. 39-50,1991
CHALLEM, Jack. Soy Isoflavones for Women`s Health. Nutrition Science 149
News Online
CHANSAKAOW, S. et al. Isoflavonoids from Pueraria mirifica and their 87
Estrogenic Activity. Planta Med., v.66,572-575, 2000.
CHENG, Tsung O. Herbal interactions with cardiac drugs. Arch. Intern. Med., 07
v. 160, n. 27, p. 870-871. 2000.
CHENG, Tsung O. Warfarin Danshen interaction. Ann Thorac Surg., v. 67, 32
p.894. 1999.
CORDELL, Geoffrey A. Biodiversity and drug discovery : a symbiotic 49
relationship. Phytochemistry, v.55, p. 463-480. 2000.
COSTA, Sônia Maria O., et al. Chemical Constituents from Lippia sidoides 106
and Cytotoxic Activiy. J. Nat. Prod.,n. 64, p. 792-795, 2001
DE SMET, Peter A.G.M. Herbal remedies. The New England Journal of 28
Medicine, v. 347, n. 25, p. 2046-2056. 2002.
DI CARLO, Giulia, et al. Flavonoids: old and new aspects of a class of natural 97
therapeutic drugs. Life Sciences, v. 65, n. 4, p. 337-353, 1999
DIEL, P. et al. In Vitro Test Systems for the Evaluation of the Estrogenic 90
Activity of Natural Products. . REVIEW. . Planta Med., v 65, 197-203, 1999.
DIEL, P. et al. In vivo Test systems for the quantitative and qualitative 91
analysis of the biological activity of phytoestrogens. . Journal of
Chromatography B, v 777, 191-202, 2002.
DINH, Long Doan, et al. Interaction of various piper methysticum cultivars 52
with CNS receptors in vitro. Planta Medica, v.67, p. 306-311. 2001
DIVI, Rao L., et al. Anti-Thyroid Isoflavones from Soybean. Isolation, 125
Characterization, and Mechanisms of Action. Biochemical Pharmacology, v.
54, p. 1087-1096, 1997
DONALD, J. et al. Black Cohosh Extract Found Ineffective in Treating Hot 96
Flashes in Women with a History of Breast Cancer. Journal of Clinical
Oncology, v 19, 2739-2745, 2001.
DRUG interaction of St. John’s wort with ciclosporin. Lancet, v. 355, p. 1912. 35
2000.
ERNST, E. Toxic heavy metals and undeclared drugs in Asian herbal 80
medicines. . TRENDS in Pharmocological Sciences, v. 23, n.3, March, 136-
139, 2002.
ERNST, E. Herb-drug interactions: pontentially important but woefully under- 20
researched. Eur. J. Clin. Pharmacol., v. 56, p. 523-524. 2000.
ERNST, E. Safety concerns about kava, The Lancet, v. 359, p. 1865. 2002. 06
ERNST, E. Second thoughts about safety of St John’s Wort. The Lancet, v. 19
354, p. 2014-2015. 1999.
ERNST, E. The risk-benefit profile of commonly used herbal therapies: 60
Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto and Kava.
Annals of Internal Medicine, v.136, n.1, p.1-16. 2002.
FINE, Anne Marie, et al. Oligomeric Proanthocyanidin Complexes: History, 139
Structure, and Phytopharmaceutical Applications. Altern. Med. Rev., v. 5, n.2,
p. 144-151, 2000. Disponivel em: www.thorne.com/altmedrev/fulltext/oligo5-
2.html
FUNG-BERMAN, A. Herb-drug interactions, Lancet, v. 355, p.134-138. 2000. 13